ReviewTherapeutic advances in musculoskeletal disease2024

What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?

Peter C Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.